about
Association of a polymorphism in a gene encoding a urate transporter with CKD progression.Linkage disequilibrium patterns and tagSNP transferability among European populations.The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients.Joint effect of insulin signaling genes on all-cause mortality.Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.Mendelian randomization: a new approach to studying epidemiology in ESRD.Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.A polymorphism in a major antioxidant gene (Kelch-like ECH-associated protein 1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study.Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity.Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling.Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients.Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end-stage renal disease.Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesityACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD PatientsPlasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patientsTissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failureNeuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patientsAn Additive Effect of Endothelial Nitric Oxide Synthase Gene Polymorphisms Contributes to the Severity of Atherosclerosis in Patients on DialysisThe E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal diseaseThe deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosisA genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based studySynergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progressionA polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study
P50
Q33715840-3F0D8BC6-6DD0-425E-85CB-A74E3741BBC5Q33938621-02EBEF8D-A696-4D61-A7C7-728707FD1729Q34615287-ADD3F4ED-6857-4517-BBD9-C441145D64D9Q34954938-6C1BA48F-2A0C-490F-9AD0-24953CD231CEQ35051231-4F0174D4-3837-4DCC-B715-DF3F5A249CD9Q36008046-1EAE10AF-5B53-45AD-98AF-9DD9F8668C57Q36375638-45E6B425-9CF4-4283-99CE-64400248BF46Q36487212-FFDF4959-C413-4BA6-A2FD-B92B0716FF3AQ38647829-12EF0351-9A50-460E-8CDA-CD5BE9255983Q40855330-17FD4482-B8BE-42DB-BF0D-9766A0B5764CQ43084391-02EAFF99-08BD-45E2-B15C-10FDF7B87075Q43933215-24F84055-F1F6-4545-939E-B11A0FFBADB6Q45891859-9015B8D6-68BD-4EFF-9EF6-7EB1CAF93294Q46418531-FFC02042-6B86-4ED1-A1FA-27C9322BB947Q46859139-AEAE266A-13FA-4CB2-835C-63E6BB0D061EQ57364389-966C1E56-54C4-48CF-BCEB-F81ED3C12E37Q57703755-8392EDD0-B8D8-440D-B93A-5C3A953DBDF7Q58946639-957EE383-6FC9-4C72-BFAB-574A2208327EQ58946805-493BADBE-A8EC-4130-8727-F99889D6F10EQ58946977-84CCA37A-69B2-4FE1-8931-CEC87FAFF1BCQ58947980-3AFBBF1F-26B0-435E-BC42-332002951383Q58949133-F06D4DC9-C989-4436-94B3-870C1366C87DQ58949784-C5D11991-A6D2-4073-A5B0-30A935EAC404Q58950920-0DB5DE2C-B0EF-4843-8AD7-D6DD52C94EAEQ85736032-4F7D7CDC-EFD1-4D0B-BB4B-E4312FE2028EQ86082216-FF4DE5AA-E630-4498-BBC0-04E20BA839E4Q87829165-FAC45B28-D188-4EEB-81D5-5B1A47A804D9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alessandra Testa
@ast
Alessandra Testa
@en
Alessandra Testa
@es
Alessandra Testa
@nl
type
label
Alessandra Testa
@ast
Alessandra Testa
@en
Alessandra Testa
@es
Alessandra Testa
@nl
prefLabel
Alessandra Testa
@ast
Alessandra Testa
@en
Alessandra Testa
@es
Alessandra Testa
@nl
P106
P1153
7103110926
P21
P31
P496
0000-0002-0529-6571